English | Español

Technology/Innovation
+ Technology/Innovation
Jamie Barrand | Nov 13, 2015

New information about ALS could lead to a treatment breakthrough
+ Technology/Innovation
Jamie Barrand | Nov 12, 2015

Phase II clinical study of Anifrolumab shows positive lupus treatment results
+ Technology/Innovation
Jamie Barrand | Nov 12, 2015

Astellas Pharma buys Ocata Therapeutics to boost ophthalmology therapies
+ Regulatory
Kim Sunderland | Nov 12, 2015

Coalition calls on feds to prevent Obamacare patient discrimination
+ Regulatory
Jamie Barrand | Nov 12, 2015

FDA says long-term use of Plavix does not change death risk
+ Regulatory
Jamie Barrand | Nov 12, 2015

Medicare announces Parts A and B premiums, deductibles for 2016
+ Regulatory
Jamie Barrand | Nov 11, 2015

FDA approves Genvoya for HIV treatment
+ Regulatory
Jamie Barrand | Nov 11, 2015

NHC recommends Robert Califf as U.S. Food and Drug Administration commissioner

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation